We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

News

News

Protelica Awarded Phase II SBIR Grant by the National Science Foundation

The $500,000 grant will develop companies’ platform technology, and will fund preclinical studies of its candidates for cardiovascular and cancer therapies.
News

Wellcome Trust Centre for Human Genetics Selects GenoLogics Solution to Manage Sequencing Data

Wellcome Trust is deploying Geneus lab and data management solution for genomics, including integrations to next generation sequencing platforms.
News

Schering-Plough Licenses Symyx Notebook for Global R&D Operations

Schering-Plough and Symyx also collaborates to develop within the Symyx Notebook a commercial metrology module built on Symyx informatics platform.
News

Chinese Researchers Sequence World's First Giant Panda Genome

Using Illumina's genome analyzer, researchers at BGI, Shenzhen de novo sequence the giant panda genome.
News

Protein Forest Expands into Europe

The new European division will support sales, product demonstrations, applications development and collaborative projects with European customers.
News

Team Finds Breast Cancer Gene Linked to Disease Spread

Researchers identify a long-sought gene affecting 30 to 40 percent of all breast cancer patients that resists traditional chemotherapies and leads to death.
News

FASgen Announces Research and License Agreement with Centocor

Centocor to discover and develop novel small molecule inhibitors of the fatty acid biosynthesis pathway via selective inhibition of FAS for use in Oncology.
News

Vampires Go to Bat for Stroke Treatment

The stroke experts are hoping a blood thinner that mimics a chemical in vampire saliva will help save brain cells in stroke patients.
News

Brain Starvation as We Age Appears to Trigger Alzheimer’s

A slow, chronic starvation of the brain as we age appears to be one of the major triggers of a biochemical process that causes some forms of Alzheimer's disease.
News

Celera and Abbott Revise Strategic Alliance from Profit Sharing to Worldwide Distribution and Royalty Agreements

New agreements include distribution arrangement for certain Celera products and royalty-bearing arrangement for m2000™ sales.
Advertisement